Targeting Probiotics in Rheumatoid Arthritis

Area of Science:

• Immunology
• Microbiology
• Gastroenterology

Background:

• Rheumatoid arthritis (RA) is a progressive inflammatory joint disease with complex causes, including genetic and gut microbiota factors.
• Gut microbiota imbalance is implicated in RA pathogenesis, highlighting the need for therapeutic interventions targeting this system.
• Lactobacillus probiotics are known for immune support and gut health, but their specific role in RA management is not fully understood.

Purpose of the Study:

• To review and analyze the current understanding of rheumatoid arthritis (RA) pathogenicity.
• To investigate the therapeutic and diagnostic functions of probiotics, specifically Lactobacillus casei and Lactobacillus acidophilus, in RA treatment.
• To explore the potential of probiotics in managing RA manifestations by modulating gut microbiota.

Main Methods:

• Literature review of existing research on rheumatoid arthritis and probiotics.
• Analysis of randomized controlled trials investigating probiotic administration in RA patients.
• Examination of studies focusing on the interaction between gut microbiota and RA.

Main Results:

• Probiotic supplementation, particularly with specific Lactobacillus strains, demonstrates anti-inflammatory benefits in RA.
• Clinical trials indicate that probiotics can improve daily functioning and alleviate RA symptoms.
• Probiotics show potential as a therapeutic strategy for managing RA by influencing the gut microbiome.

Conclusions:

• Probiotics represent a promising avenue for the treatment and prevention of rheumatoid arthritis.
• Modulating gut microbiota with probiotics may offer a novel approach to managing RA.
• Further investigation into the mechanisms of Lactobacillus spp. in RA is warranted for optimized therapeutic use.